Factors Affecting the Choice of Lobbing Strategies of Pharmaceutical Transnational Companies Entering Developed and Emerging Markets by the Example of Pfizer in Russia, the EU and China

Global pharmaceutical industry is one of the fastest and rapidly developing market sectors. It is supposed to be a unique industry, which is responsible not only for the convenience of the consumer, but also for their health. Pharmaceutical industry is also significant for economy of every particular country, because the level of its development is a direct indicator of the whole economy development. Current research covers the topic of factors affecting the choice of lobbying strategies of pharmaceutical transnational companies entering developed and emerging markets. The relevance of the work is dictated with the fact that lobbying has several gaps in the theoretical background, especially in the sphere of pharmaceutical products, which have strict regulations from the government of every particular country. During the study we have analyzed fundamental studies on the topic of lobbying strategies applied by international pharmaceutical corporations, also conducted case study of Pfizer company’s lobbying activities in the home country (the US), as well as EU, Russia and China. On the basis of data gathered during the research we have conducted comparative analysis of numerical data of Pfizer company, and assessed the company activities according to identified factors, which influence the choice of lobbying strategy.